Drugs and Research - Clinical Research Informer

Vertex’s non-opioid pain drug gets FDA approval in milestone for company and research

Bio Pharma Dive

JANUARY 30, 2025

Despite high demand for an option like Journavx, doctors fear the drug’s price could be a major hangup for insurers, potentially limiting patients’ ability to access it.

FDA Approval

FDA Approval Doctor Doctors Drugs

Biopharma & medical devices cos view advanced infrastructure to propel manufacturing & new drug development

AuroBlog - Aurous Healthcare Clinical Trials blog

NOVEMBER 21, 2024

Critical infrastructure in biopharma and medical devices plays a vital role in enabling innovation, bolstering research and development, and ensuring the production of novel drugs and products. It ensures scalability, quality control, and regulatory compliance.

Manufacturing

Manufacturing Development Compliance Drugs

NIH funds research for three experimental ALS drugs

Bio Pharma Dive

OCTOBER 6, 2023

The funding, which is part of ACT for ALS, will support expanded access studies of drugs developed by Prilenia Therapeutics, Clene Nanomedicine and Rapa Therapeutics.

Drugs

Drugs Research Development

Webinars

Bridging Innovation & Patient Care: The Growing Role of AI

MORE WEBINARS

New research could ease concerns over suicide risk of obesity drugs

Bio Pharma Dive

SEPTEMBER 3, 2024

While results from two after-the-fact analyses were “reassuring,” outside experts urged “continued vigilance” to ensure GLP-1 drugs don’t worsen problems in people with preexisting mental health conditions.

Drugs

Drugs Research

Bridging Innovation & Patient Care: The Growing Role of AI

Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health

AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. From Research to Real-World Care 🌎 Understand how AI-driven advancements are shaping personalized treatments and patient outcomes.

Clinical Trials

Upstream Bio, a richly funded startup, reveals its lead drug and research plans

Bio Pharma Dive

JUNE 2, 2022

Backed by $200 million in funding and led by biotech veteran Samantha Truex, Upstream is developing a clinical-stage inflammatory disease drug acquired from Astellas last year.

Drugs

Drugs Research Development

Eisai hunts for next Alzheimer’s drug with new research pact

Bio Pharma Dive

APRIL 22, 2024

A collaboration with BioArctic will focus on a technology designed to more effectively deliver drugs in the brain, following similar efforts by Roche.

Drugs

Drugs Research

Odyssey recruits news investors to fund precision drug research

Bio Pharma Dive

OCTOBER 13, 2022

A $168 million Series B round brings Odyssey’s total funding to date near $400 million, helping the startup support a growing pipeline of cancer and immune disease drug candidates.

Drugs

Drugs Research

As ALS research booms, one treatment center finds itself in the spotlight

Bio Pharma Dive

DECEMBER 20, 2023

The Healey center is at the front of ALS research and care, earning acclaim from patients, doctors and scientists. Still, the complexities of the disease and of drug development have brought hard-felt losses.

Research

Research Doctor Doctors Scientist

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? This new guidance will clearly impact the clinical research field, but how? In this exclusive webinar, Dr. Ben Locwin will discuss the potential effects of this draft, along with the pharmacological and toxicological considerations for optimizing doses of prescription drugs.

Clinical Research

AltruBio lands up to $225M after shift to immune drug research

Bio Pharma Dive

MAY 21, 2024

Since pivoting from oncology, the startup has raised close to $300 million and advanced an ulcerative colitis drug into mid-stage testing.

Drugs

Drugs Research

Innovation in Autoimmune and Bone Health Research: Driving Progress for Better Patient Outcomes

Worldwide Clinical Trials

OCTOBER 14, 2024

Fortunately, advances in clinical research are providing hope for better treatments and outcomes. With the support of global networks like ours at Worldwide Clinical Trials (Worldwide), autoimmune and bone health research is accelerating, providing new solutions to patients around the world.

Research

Research Clinical Trials Clinical Trials Immune Response

Foundery, a new biotech venture firm, sets out to speed early immune drug research

Bio Pharma Dive

AUGUST 22, 2023

Billing itself as both a scientific and investment partner, Foundery aims to provide research grants and drug development support to researchers developing new immunotherapies.

Research

Research Drugs Development

Innovating in Autoimmune and Bone Health Research: Driving Progress for Better Patient Outcomes

Worldwide Clinical Trials

OCTOBER 14, 2024

Fortunately, advances in clinical research are providing hope for better treatments and outcomes. With the support of global networks like ours at Worldwide Clinical Trials (Worldwide), autoimmune and bone health research is accelerating, providing new solutions to patients around the world.

Research

Research Clinical Trials Clinical Trials Immune Response

Deliver Fast, Flexible Clinical Trial Insights with Spotfire

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management.

Clinical Trials

India takes centre-stage in clinical trials for HIV/AIDS drug

AuroBlog - Aurous Healthcare Clinical Trials blog

DECEMBER 5, 2024

India has taken centre-stage in clinical trials for HIV/AIDS drug as there are several ongoing clinical trials in India focused on advancing HIV treatment. These trials are investigating new drug candidates, therapies, and approaches to manage HIV more effectively and potentially cure it.

Clinical Trials

Clinical Trials Clinical Trials Trials Drugs

Biogen, Ionis shelve ALS drug following study failure

Bio Pharma Dive

MAY 16, 2024

While results indicated the drug works as intended, it didn’t have enough of an effect on a protein that’s become integral to many ALS research programs.

Drugs

Drugs Protein Research

Biotechs reveal layoffs, research revamps in third quarter earnings

Bio Pharma Dive

NOVEMBER 16, 2022

Tricida, Harpoon, Freeline and three other small drug developers have this week announced plans to cut staff or to reprioritize their drug development.

Research

Research Development Drugs

Novo Nordisk partners with Microsoft for AI-driven drug discovery

Pharmaceutical Technology

SEPTEMBER 13, 2022

Novo Nordisk has signed a new strategic partnership with Microsoft to expedite the discovery and development of drugs leveraging big data and artificial intelligence (AI). The post Novo Nordisk partners with Microsoft for AI-driven drug discovery appeared first on Pharmaceutical Technology.

Drugs

Drugs Big Data Development Research

Researchers at IISc find Pranlukast has potential applications for TB therapy

AuroBlog - Aurous Healthcare Clinical Trials blog

JUNE 3, 2024

Researchers at the Indian Institute of Science (IISc) have found that Pranlukast have the potential applications in tuberculosis (TB) therapy. The researchers are of the view that it could enhance the healing process of lung tissues infected with TB.

Research

Research Drugs Clinical Trials Clinical Trials

Cloud robotics labs are accelerating drug discovery and development

Pharmaceutical Technology

OCTOBER 28, 2022

Drug discovery and development is an incredibly expensive and time-consuming process, taking between 12 and 18 years, and costing on average between $2 billion and $3 billion. Robots can improve drug discovery and development. Remote-controlled robotic labs.

Development

Development Drugs Pharma Companies Life Science

August 22, 2023: Distributed Research Network Shares Opportunities and Challenges for Pragmatic Research Embedded in Health Insurance Plans

Rethinking Clinical Trials

AUGUST 22, 2023

In an article published this month in Clinical Trials , researchers from the NIH Pragmatic Trials Collaboratory’s Distributed Research Network share opportunities for conducting pragmatic trials embedded in health insurance plans. For more, see the Distributed Research Network page on the Living Textbook or read the full article.

Research

Research Clinical Trials Clinical Trials Trials

Key Considerations for Generic Drug Stability Testing

Drug Patent Watch

MARCH 12, 2025

The Unseen Heroes of Generic Drugs: Stability Testing 101 As a consumer, have you ever stopped to think about the rigorous process that goes into bringing a generic version of your favorite medication to market? For generic drug manufacturers, stability testing is a critical step in the development process.

Generic Drugs

Generic Drugs Drugs Manufacturing Branding

FDA, in another test of its flexibility, agrees to review Biogen's closely watched ALS drug

Bio Pharma Dive

JULY 26, 2022

Known as tofersen, the drug failed in the main study being used to support its approval. But an apparent effect on a protein of interest in ALS research has Biogen convinced the treatment will pass muster with regulators.

Drugs

Drugs Protein Regulation Research

Type 2 Diabetes Drug Linked to 35% Lower Dementia Risk in Patients

AuroBlog - Aurous Healthcare Clinical Trials blog

SEPTEMBER 11, 2024

(nomadsoulphotos/Canva) A Korean study published recently suggests people with type 2 diabetes who are prescribed a particular class of drug might be at a significantly lower risk of dementia.

Drugs

Drugs Research Clinical Trials Clinical Trials

Psychiatry Clinical Trials: Inclusive, Patient-Centric Approaches for Mental Health Research

XTalks

DECEMBER 19, 2024

Especially as we exited the blockbuster drug period of psychiatric development and trials were failing with huge placebo effects, I think we started realizing that the patients going into trials were not the real-world patients that were getting treated with drugs in the clinic.

Clinical Trials

Clinical Trials Clinical Trials Trials Research

Ethnopharmacology: traditional medicine and modern drug discovery

Pharmaceutical Technology

APRIL 24, 2023

However, the reality is that traditional medicine has been the source of lead identification in modern drug discovery. Ethnopharmacology has been an important basis for modern medicine The estimated percentage of pharmaceutical drugs available today that are sourced from natural products varies.

Medicine

Medicine Drugs Production Research

Scientists Think This Psychedelic Drug Could Help Treat Anorexia

AuroBlog - Aurous Healthcare Clinical Trials blog

MAY 27, 2024

The psychedelic drug psilocybin (as found in ‘magic’ mushrooms) has promising potential as a treatment for the eating disorder anorexia nervosa, according to new research that looked at its effects on an animal model of the condition.

Scientist

Scientist Drugs Research Clinical Trials

FTC, in unusual move, leads Sanofi to terminate a drug research deal

Bio Pharma Dive

DECEMBER 12, 2023

Just before clearing Pfizer’s buyout of Seagen, the regulator threatened to block Sanofi’s licensing deal with Maze Therapeutics, a challenge the biotech called ‘‘unprecedented.”

Licensing

Licensing Licensing Regulation Research

This Drug Shows Potential to Stop Migraines Before They Begin

AuroBlog - Aurous Healthcare Clinical Trials blog

SEPTEMBER 16, 2024

(Francesco Carta Fotografo/Moment/Getty Images) Migraines and headaches affect billions of people worldwide, and a new study suggests the drug ubrogepant can put a stop to the pain even before a migraine has fully kicked in.

Drugs

Drugs Branding Research Clinical Trials

Brain disease startup Neumora draws more funding for ambitious research plan

Bio Pharma Dive

OCTOBER 11, 2022

Launched last year to change how drugs for brain diseases are made, the biotech has now raised about $650 million to build a pipeline that includes two clinical-stage medicines.

Research

Research Medicine Drugs

Bristol Myers’ neuroscience research head explains the big pharma’s return to brain drugs

Bio Pharma Dive

OCTOBER 27, 2023

In a wide-ranging interview, Bristol Myers’ Ken Rhodes talked biomarkers, diseases of interest and why the company is far from done with neuroscience-focused deals.

Research

Research Drugs

How epilepsy researchers are moving the needle past anti-seizure treatments

Pharmaceutical Technology

FEBRUARY 13, 2023

While several therapeutics are available for treating symptoms associated with epilepsy, researchers and patients have strongly called out the need for more holistic treatments that would address the condition as a whole. Meanwhile, others are researching the link between gene variation and different responses to treatments.

Research

Research Gene Gene Therapy Genome

Pfizer research chief Dolsten to step down, with company at a crossroads

Bio Pharma Dive

JULY 9, 2024

The company has begun searching for a successor to Dolsten, who oversaw more than 35 drug and vaccine approvals but also some notable setbacks during his time as Pfizer’s top scientist.

Scientist

Scientist Research Vaccination Vaccine

Common Blood Pressure Drug Increases Lifespan And Slows Aging in Animals

AuroBlog - Aurous Healthcare Clinical Trials blog

MAY 2, 2024

The hypertension drug rilmenidine has been shown to slow down aging in worms, an effect that in humans could hypothetically help us live longer and keep us healthier in our latter years. Previous research has shown rilmenidine mimics the effects of caloric restriction on a cellular level.

Drugs

Drugs Research Clinical Trials Clinical Trials

Genentech takes up a deal to make ‘molecular glue’ drugs

Bio Pharma Dive

SEPTEMBER 20, 2023

Targeted protein degradation has emerged as one of the more competitive areas of pharmaceutical research in recent years as scientists develop new ways to reach difficult-to-drug targets.

Drugs

Drugs Protein Scientist Development

Clinical Trial Shows One Drug Performs Better Than Ozempic For Weight Loss

AuroBlog - Aurous Healthcare Clinical Trials blog

JULY 18, 2024

Patients taking Eli Lilly’s new drug Mounjaro achieved significantly greater weight loss than those on Novo Nordisk’s Ozempic, a head-to-head study published Monday showed.

Clinical Trials

Clinical Trials Clinical Trials Drugs Trials

Genesis raises $200 million for AI drug discovery research

Bio Pharma Dive

AUGUST 21, 2023

The Series B round brings the total funding for Genesis, a California startup backed by Andreessen Horowitz and Nvidia’s VC arm, to over $280 million.

Research

Research Drugs

Pharmacognosy and Drug Patents: Unveiling Nature’s Medicinal Treasures

Drug Patent Watch

DECEMBER 9, 2024

In the vast realm of pharmaceutical research and development, there’s a fascinating intersection between ancient wisdom and modern science. This intersection is where pharmacognosy meets drug patents, creating a unique landscape that shapes the future of medicine. What is a Drug Patent?

Medicine

Medicine Drugs Production Development

PureTech, tweaking research, trims a ‘small number’ of positions

Bio Pharma Dive

FEBRUARY 14, 2023

The biotech company creator is deprioritizing work on a drug delivery technology called Orasome after what it described as a “key go/no go” experiment.

Drug Delivery

Drug Delivery Research Drugs

Roche buys into Alnylam heart drug in cardiovascular research bet

Bio Pharma Dive

JULY 24, 2023

The Swiss pharma company is the latest large drugmaker to invest big in an experimental heart treatment, after years of prioritizing medicines for cancer and immune diseases.

Pharma Companies

Pharma Companies Research Medicine Drugs

XtalPi announces $250m AI drug discovery collaboration with Eli Lilly

Pharmaceutical Technology

MAY 31, 2023

XtalPi has made a partnership deal with US-based Eli Lilly to leverage artificial intelligence (AI) for drug discovery. The two companies will use XtalPi’s integrated AI capabilities and robotics platform for the de novo [without consideration of previous instances] design and delivery of drug candidates for an undisclosed target.

Drugs

Drugs Development Research

No drugs for prions: could new approaches alleviate therapeutic scarcity?

Pharmaceutical Technology

AUGUST 5, 2022

This is also why academic research is dominant here, as companies are hesitant to take this on, adds Holger Wille, PhD, associate professor at the Centre for Prions and Protein Folding Diseases at the University of Alberta. No progress in drug discovery. “We We have made astonishing progress in understanding the disease….On

Drugs

Drugs Protein Vaccine Vaccination

NextCure to lay off 37% of staff, dial back research plans

Bio Pharma Dive

MARCH 21, 2024

The job cuts at the cancer drug developer will primarily impact manufacturing roles, but will touch on several other parts of the organization, the company said.

Research

Research Manufacturing Development Drugs

Vertex’s non-opioid pain drug gets FDA approval in milestone for company and research

Biopharma & medical devices cos view advanced infrastructure to propel manufacturing & new drug development

Webinars

Trending Sources

NIH funds research for three experimental ALS drugs

Webinars

New research could ease concerns over suicide risk of obesity drugs

Bridging Innovation & Patient Care: The Growing Role of AI

Upstream Bio, a richly funded startup, reveals its lead drug and research plans

Eisai hunts for next Alzheimer’s drug with new research pact

Odyssey recruits news investors to fund precision drug research

As ALS research booms, one treatment center finds itself in the spotlight

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

AltruBio lands up to $225M after shift to immune drug research

Innovation in Autoimmune and Bone Health Research: Driving Progress for Better Patient Outcomes

Foundery, a new biotech venture firm, sets out to speed early immune drug research

Innovating in Autoimmune and Bone Health Research: Driving Progress for Better Patient Outcomes

Deliver Fast, Flexible Clinical Trial Insights with Spotfire

India takes centre-stage in clinical trials for HIV/AIDS drug

Biogen, Ionis shelve ALS drug following study failure

Biotechs reveal layoffs, research revamps in third quarter earnings

Novo Nordisk partners with Microsoft for AI-driven drug discovery

Researchers at IISc find Pranlukast has potential applications for TB therapy

Cloud robotics labs are accelerating drug discovery and development

August 22, 2023: Distributed Research Network Shares Opportunities and Challenges for Pragmatic Research Embedded in Health Insurance Plans

Key Considerations for Generic Drug Stability Testing

FDA, in another test of its flexibility, agrees to review Biogen's closely watched ALS drug

Type 2 Diabetes Drug Linked to 35% Lower Dementia Risk in Patients

Psychiatry Clinical Trials: Inclusive, Patient-Centric Approaches for Mental Health Research

Ethnopharmacology: traditional medicine and modern drug discovery

Scientists Think This Psychedelic Drug Could Help Treat Anorexia

FTC, in unusual move, leads Sanofi to terminate a drug research deal

This Drug Shows Potential to Stop Migraines Before They Begin

Brain disease startup Neumora draws more funding for ambitious research plan

Bristol Myers’ neuroscience research head explains the big pharma’s return to brain drugs

How epilepsy researchers are moving the needle past anti-seizure treatments

Pfizer research chief Dolsten to step down, with company at a crossroads

Common Blood Pressure Drug Increases Lifespan And Slows Aging in Animals

Genentech takes up a deal to make ‘molecular glue’ drugs

Clinical Trial Shows One Drug Performs Better Than Ozempic For Weight Loss

Genesis raises $200 million for AI drug discovery research

Pharmacognosy and Drug Patents: Unveiling Nature’s Medicinal Treasures

PureTech, tweaking research, trims a ‘small number’ of positions

Roche buys into Alnylam heart drug in cardiovascular research bet

XtalPi announces $250m AI drug discovery collaboration with Eli Lilly

No drugs for prions: could new approaches alleviate therapeutic scarcity?

NextCure to lay off 37% of staff, dial back research plans

Stay Connected